1. Home
  2. PUBM vs XOMA Comparison

PUBM vs XOMA Comparison

Compare PUBM & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PUBM
  • XOMA
  • Stock Information
  • Founded
  • PUBM 2006
  • XOMA 1981
  • Country
  • PUBM United States
  • XOMA United States
  • Employees
  • PUBM N/A
  • XOMA N/A
  • Industry
  • PUBM Computer Software: Prepackaged Software
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PUBM Technology
  • XOMA Health Care
  • Exchange
  • PUBM Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • PUBM 406.5M
  • XOMA 457.6M
  • IPO Year
  • PUBM 2020
  • XOMA N/A
  • Fundamental
  • Price
  • PUBM $8.75
  • XOMA $34.79
  • Analyst Decision
  • PUBM Buy
  • XOMA Strong Buy
  • Analyst Count
  • PUBM 11
  • XOMA 2
  • Target Price
  • PUBM $18.05
  • XOMA $69.50
  • AVG Volume (30 Days)
  • PUBM 649.1K
  • XOMA 47.8K
  • Earning Date
  • PUBM 11-10-2025
  • XOMA 11-05-2025
  • Dividend Yield
  • PUBM N/A
  • XOMA N/A
  • EPS Growth
  • PUBM N/A
  • XOMA N/A
  • EPS
  • PUBM N/A
  • XOMA N/A
  • Revenue
  • PUBM $292,208,000.00
  • XOMA $44,952,000.00
  • Revenue This Year
  • PUBM N/A
  • XOMA $88.91
  • Revenue Next Year
  • PUBM $1.40
  • XOMA $13.80
  • P/E Ratio
  • PUBM N/A
  • XOMA N/A
  • Revenue Growth
  • PUBM 3.53
  • XOMA 194.98
  • 52 Week Low
  • PUBM $7.01
  • XOMA $18.35
  • 52 Week High
  • PUBM $17.74
  • XOMA $39.92
  • Technical
  • Relative Strength Index (RSI)
  • PUBM 57.39
  • XOMA 46.03
  • Support Level
  • PUBM $7.88
  • XOMA $33.04
  • Resistance Level
  • PUBM $8.94
  • XOMA $35.71
  • Average True Range (ATR)
  • PUBM 0.27
  • XOMA 1.84
  • MACD
  • PUBM 0.09
  • XOMA -0.36
  • Stochastic Oscillator
  • PUBM 89.57
  • XOMA 29.36

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: